DK1948194T3 - Anvendelse af clodronsyre til behandling af hovsenebenssyndrom - Google Patents
Anvendelse af clodronsyre til behandling af hovsenebenssyndromInfo
- Publication number
- DK1948194T3 DK1948194T3 DK06818441.5T DK06818441T DK1948194T3 DK 1948194 T3 DK1948194 T3 DK 1948194T3 DK 06818441 T DK06818441 T DK 06818441T DK 1948194 T3 DK1948194 T3 DK 1948194T3
- Authority
- DK
- Denmark
- Prior art keywords
- hoof
- treatment
- clodronic acid
- sinus syndrome
- sinus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005053512A DE102005053512A1 (de) | 2005-11-09 | 2005-11-09 | Verwendung von Clodronsäure zur Behandlung von Podotrochlose |
PCT/EP2006/010753 WO2007054309A2 (de) | 2005-11-09 | 2006-11-09 | Verwendung von clodronsäure zur behandlung von podotrochlose |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1948194T3 true DK1948194T3 (da) | 2014-10-06 |
Family
ID=37946748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06818441.5T DK1948194T3 (da) | 2005-11-09 | 2006-11-09 | Anvendelse af clodronsyre til behandling af hovsenebenssyndrom |
Country Status (12)
Country | Link |
---|---|
US (1) | US7781420B2 (da) |
EP (1) | EP1948194B8 (da) |
JP (1) | JP5483879B2 (da) |
AU (1) | AU2006311227B2 (da) |
CA (1) | CA2627942C (da) |
DE (1) | DE102005053512A1 (da) |
DK (1) | DK1948194T3 (da) |
ES (1) | ES2503342T3 (da) |
NZ (1) | NZ568215A (da) |
PL (1) | PL1948194T3 (da) |
PT (1) | PT1948194E (da) |
WO (1) | WO2007054309A2 (da) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
PT854724E (pt) * | 1995-09-29 | 2005-08-31 | Novartis Ag | Metodo de tratar a doenca navicular em cavalos |
FR2784031B1 (fr) * | 1998-10-02 | 2002-02-01 | Sanofi Elf | Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries |
US7277744B2 (en) * | 1999-03-22 | 2007-10-02 | Schaefer Allan L | Early detection of inflammation and infection using infrared thermography |
US6280741B1 (en) * | 1999-08-19 | 2001-08-28 | Ed C. Jessup | Equine treatment and method of administering such treatment |
US6638920B2 (en) * | 2000-07-21 | 2003-10-28 | Merck & Co., Inc. | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
US6635236B2 (en) * | 2001-08-10 | 2003-10-21 | Baer Knut | Method for treating podotrochlosis |
US20050153359A1 (en) * | 2002-03-11 | 2005-07-14 | Schaefer Allan L. | Method for the evaluation of velvet antler |
-
2005
- 2005-11-09 DE DE102005053512A patent/DE102005053512A1/de not_active Withdrawn
-
2006
- 2006-11-09 JP JP2008539340A patent/JP5483879B2/ja active Active
- 2006-11-09 ES ES06818441.5T patent/ES2503342T3/es active Active
- 2006-11-09 NZ NZ568215A patent/NZ568215A/en unknown
- 2006-11-09 PT PT68184415T patent/PT1948194E/pt unknown
- 2006-11-09 DK DK06818441.5T patent/DK1948194T3/da active
- 2006-11-09 WO PCT/EP2006/010753 patent/WO2007054309A2/de active Application Filing
- 2006-11-09 AU AU2006311227A patent/AU2006311227B2/en active Active
- 2006-11-09 PL PL06818441T patent/PL1948194T3/pl unknown
- 2006-11-09 EP EP06818441.5A patent/EP1948194B8/de active Active
- 2006-11-09 CA CA2627942A patent/CA2627942C/en active Active
- 2006-11-09 US US12/084,587 patent/US7781420B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2503342T3 (es) | 2014-10-06 |
PL1948194T3 (pl) | 2014-12-31 |
AU2006311227B2 (en) | 2012-08-30 |
EP1948194B8 (de) | 2014-08-13 |
CA2627942A1 (en) | 2007-05-18 |
NZ568215A (en) | 2011-06-30 |
DE102005053512A1 (de) | 2007-06-28 |
US7781420B2 (en) | 2010-08-24 |
JP5483879B2 (ja) | 2014-05-07 |
US20090253657A1 (en) | 2009-10-08 |
WO2007054309A2 (de) | 2007-05-18 |
PT1948194E (pt) | 2014-09-24 |
AU2006311227A1 (en) | 2007-05-18 |
WO2007054309A3 (de) | 2008-02-07 |
CA2627942C (en) | 2015-12-29 |
EP1948194B1 (de) | 2014-07-02 |
JP2009514922A (ja) | 2009-04-09 |
EP1948194A2 (de) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1008I2 (fr) | Composition immunogène | |
DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
CY2014030I1 (el) | Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate | |
DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
ATE525088T1 (de) | Kombinationstherapie | |
DE602005008726D1 (de) | Verwendet | |
DE602006004866D1 (de) | Katheter | |
DK1876897T3 (da) | Aktivstofkombinationer | |
NO20070251A (no) | Brønnbehandling | |
DE602005002689D1 (de) | Luftbefeuchter | |
DE502006008090D1 (de) | Wirkstoffkombinationen | |
DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
DK1937633T3 (da) | Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme | |
DK1959988T3 (da) | Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder | |
DK2216021T3 (da) | Farmaceutisk sammensætning til behandling af overaktiv blære | |
DE602006001386D1 (de) | Faserbehandlungsmittel | |
DK1709082T3 (da) | Sammensætning til behandling af patologi knyttet til MSRV/HERV-W | |
ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
MA28846B1 (fr) | Composition biologiquement active | |
DK1940447T3 (da) | Behandling af neurodegenrative lidelser | |
DE112006001760A5 (de) | Katheter | |
DE112006002041A5 (de) | Pharmazeutisch wirksame Zusammensetzung zur Behandlung von Diabetes | |
DK2001499T3 (da) | Anvendelse af TGS-6 til behandling af osteoporose |